We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 2.35% | 4.35 | 4.20 | 4.50 | 4.35 | 4.25 | 4.25 | 142,382 | 08:05:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.90 | 26.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/12/2019 15:29 | Brucie5 I personally don't place any relevance in those charts relative to Eden. Their business model has changed during that period and that also hit an intraday high of 26-27p during that period and look at the difference of where Eden is now in the commercial curve as opposed to then. You may have seen this chart before?! hxxps://www.stocktra I believe in that chart and the psychology that it refers to. Eden in my opinion is in the optimism stage........still and has yet to enable excitement! If Eden is ever smart enough to get the share price to the euphoric stage, their challenge will be to avoid the dip and the future rise. Moreso, they should try to avoid 'the camels hump' and underpin and level out any potential dip. That of course would need pre-planning and some smart manoeuvring to mitigate the dip. Nonetheless, actions could be taken to hopefully offset the depth of any downside. You could say Eden's investors feel some of those downside negative emotions and rightly side, but allowing for the chart suggesting that these emotions follow in their logical order, Eden has never got past stage one. | investingisatrickygame | |
27/11/2019 22:05 | On the 5 year chart this is the floor, with following upsides: 2014; 7/24 2016; 7/12-14 2018; 7-16. Jak has been predicting 2p for several years. My personal hunch is that we will have news before Christmas that will cause history to repeat itself. The bod will be all too aware of the risks of disappointment. | brucie5 | |
25/11/2019 14:58 | Well, lovely new website. hxxps://www.edenrese | brucie5 | |
25/11/2019 13:41 | 727 of 727 Ironic Cartoons from the fella who is the cartoon character .. who can't say Cedroz | supersonico | |
21/11/2019 06:47 | Direction of travel.. News Creating an open network for agriculture and powering new levels of sustainable growth, UPL acquires Laoting Yoloo Bio-technology Co, Ltd, an agrochemical company based in Heibei Province, China. | supersonico | |
17/11/2019 18:19 | Investing, Eden have a Parallel formulation issue with TT and CAP imo. They have I assume been unable because of NDA's or unwilling to tell us in any great detail about the nature of the issue. One thing we know is that their is a Bayer formulation issue and Eden have tried to keep clear blue water between TT and Bayer by telling us the issues are unrelated. Formulation vs Shelf life. I don't believe them, they are linked imo but I do get that NDA's prevent them from telling us what's really happening so we get all sorts of fancy 'in the warehouse' excuses to cover the trail. This to my mind explains the PR blackout. I do expect a big announcement or two and then miraculously trusting Eden will be back in fashion. That I hope will coincide with some good Cedroz news and we can lift the anchor. Just go back over the years to every Eden CAP/TT announcement and replace the words 'short order' in the coming months' shelf life blah blah with... 'as soon as we resolve the formulation issues, ...and it all makes sense.. to me at least. | supersonico | |
17/11/2019 17:26 | Super, I don't think Eden, sadly, is off to the races yet and they have given us no indication they are, except the Eastman deal when it's in full flow. They still need to bridge the information, education, trust gap between today and then the share price as a mechanism for trust is a powerful one. There is a lot around trust at the moment, both tech and people and Eden is no different. | investingisatrickygame | |
14/11/2019 13:09 | 712 of 712 Eden formulation trust Formula; Mev/Ced works..Trusted TT/CAP/ needed tweaking. Trust suspended. Bayer/ TT announcing TT/ CAP+++ enhanced formulation =Eden Trust reboot. Off to the races. | supersonico | |
14/11/2019 12:50 | Post702. 'But the proof of the pudding is in the eating. If the product doesn't sell then logically you should accept the evidence that there is something wrong with your initial analysis'. Fascinating how FraudyJoknife who can't incorporate Cedroz into any sentence he makes or any projections has the laughable and embarrassingly infantile cheek to criticise others 'initial analysis'. Joknife LOL . | supersonico | |
05/11/2019 11:39 | Is 'Any day now' longer than 'In Short Order'? More accurate would be 'when we're happy with the tweaked formulation' which in a remarkable fluke of parallel serendipity and synchronicity we will find out is equally as long as 'in the coming months'. I'd be more explicit but my self imposed NDA's (SINDA's) strictly prohibit further comment. | supersonico | |
04/11/2019 17:47 | Any day now... | brucie5 | |
02/11/2019 14:48 | Toxic effects of glyphosate on intestinal morphology, antioxidant capacity and barrier function in weaned piglets | supersonico | |
02/11/2019 08:33 | The bell tolls again for all conventional chemistry....News The Benefits of Bacteria in Organic Apples Matt Miles A new study shows there is more “good” bacteria in organic apples. Sophisticated research on the microbiome of the foods we eat is becoming more common, and for good reason. Recent technological advances have provided stunning insights into the microbiome of the human gut, and as many are now realizing, these microbiota may have profound effects on our health. Of course, the gut microbiome is heavily influenced by the foods we feed it. “The microbiome and antioxidant profiles of fresh produce may one day become standard nutritional information, displayed alongside macronutrients, vitamins and minerals to guide consumers,” Birgit Wassermann, one of the study’s authors, told the journal. ……&hel It's still there:) 'There is significant scope for the further exploitation of the Company’s core technologies beyond crop protection'. | supersonico | |
01/11/2019 09:47 | I assume they are not resonating with the right audience. We don't have any PR from our appointed company, but I imagine that is an output of remit. And the investor communications as you say, could be better. With this likely to continue based on past performance, I think they need a transactional deal to mobilise the price. | investingisatrickygame | |
01/11/2019 09:31 | But we are , as you say in the right place at the right time and we are poised but why is this not translating ?? | bjlk | |
01/11/2019 09:06 | And yet Super, there is still a lack of demand for Eden's shares, even though they're in the right space at the right time. | investingisatrickygame | |
31/10/2019 07:34 | Lets play .. Spot Eden parallel delay Collaborators or Lets play..which one/s knows where the TT products have all gone? We don't promise you the moon - We are down to earth: Biologicals by Bayer @ ABIM in Basel 2019 For those concerned that this post may challenge my own self imposed NDA's criteria.. I've double checked.. It's a fine line and a gnat Whisker and down to interpretation ..but it does not. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions